lead and support your drug development programs through each phase of the preclinical process. In addition, Noble offers a range of services for production of protein drug candidates in mammalian and microbial systems – from development of expression vectors and stable cell lines to growth medium optimization, protein purification, analytical services and process scale-up.

With proof of concept studies, early safety assessments and other pre-IND services, we are committed to providing a strong scientific foundation to empower your preclinical decisions.